MDXG - MiMedx appoints deal maker Joseph Capper as new CEO
- Wound care company MiMedx Group ( NASDAQ: MDXG ) said on Monday that Joseph Capper, a MedTech and Life Sciences veteran with a track record in M&A, has been appointed as its chief executive officer with immediate effect.
- Todd Newton, who has functioned as the company’s interim CEO since September 2022, will remain a board member.
- Capper has nearly 30 years of experience in the MedTech, and Life Sciences sector MiMedx ( MDXG ) said. In his most recent role as the CEO of BioTelemetry, Capper led a significant turnaround of the microcap before Royal Philips ( PHG ) ( OTCPK:RYLPF ) finally acquired it for $2.8B.
- Capper has also served as President and CEO of Home Diagnostics and CCS Medical, which were also acquired at substantial premiums from his appointment.
- “I am extremely excited for the opportunity to lead MIMEDX at this pivotal juncture in the company’s evolution,” Clapper remarked.
- MiMedx ( MDXG ) shares have lost ~13% over the past 12 months, as indicated in this graph.
For further details see:
MiMedx appoints deal maker Joseph Capper as new CEO